Format

Send to

Choose Destination
Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):49-53.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Author information

1
Department of Gastroenterology, Hopital Erasme Brussels, Belgium.
2
Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
3
Department of Gastroenterology, Centre Hospitalier Universitaire de Liege, Belgium.
4
Department of Gastroenterology - Ghent University Hospital - Ghent University, Belgium.
5
Department of Gastroenterology, Cliniques Universitaires Saint-Luc UCL Bruxelles, Belgium.
6
Department of Gastroenterology, AZ Sint Lucas Brugge, Belgium.
7
Department of Gastroenterology, Imeldaziekenhuis, Bonheiden, Belgium.
8
Department of Gastroenterology, AZ Delta Roeselare, Belgium.
9
Department of Gastroenterology, CHU UCL Mont-Godinne, Belgium.

KEYWORDS:

Crohn's disease; anti-TNF; biosimilar; inflammatory bowel disease; ulcerative colitis

PMID:
29562378
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center